OakChart

Accuray Inc

ARAYHealthcare·Medical Devices·USA·Nano·NASD·Nov 11 • 2:00 PM ET

3.33+0.13 (4.23%)
2026-11-11 20:02 CET
Market cap
9.57 USD m
Revenue, TTM
394.53 USD m
Net income, TTM
-17.38 USD m
Free cash flow, TTM
-27.90 USD m
EPS diluted, TTM
-6.06
P/E
-
Compare

Price

ARAY against its 20, 50 and 200-day averages
2050200beatearnings
10.0020.0030.0040.004.7M9.4MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26ARAYclose 3.3320-day 5.2350-day 8.01200-day 13.623.33

93.0% under the 52-week high of 47.60 on 11 Nov 2025. 52-week low 2.88 on 10 Nov 2026. Last 15 sessions, 128.3% high to low

Profile

ARAY
52-week range, 1% of the way up
2.8847.60

Accuray, Inc. is a radiation therapy company, which engages in manufacturing medical equipment. It develops, manufactures, sells, and supports medical solutions. The company was founded by John R. Adler in 1990 and is headquartered in Madison, WI.

Employees809
IPOFeb 08, 2007
Beta1.44
ATR, 14d0.82
Rel volume0.47
Short float4.90%
Insider own4.81%

Snapshot

6 groups

Valuation

Index-
Market Cap9.97M
Enterprise Value102.86M
Income-17.38M
Sales394.53M
Book/sh17.77
Cash/sh14.36
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees809
IPOFeb 08, 2007

Ratios

P/E-
Forward P/E-
PEG-
P/S0.03
P/B0.19
P/C0.23
P/FCF-
EV/EBITDA9.16
EV/Sales0.26
Quick Ratio0.69
Current Ratio1.55
Debt/Eq2.56
LT Debt/Eq2.29
Option/ShortYes / Yes

Earnings

EPS (ttm)-6.06
EPS next Y-
EPS next Q-
EPS this Y-
EPS next Y-
EPS next 5Y-
EPS past 3/5Y-60.07% -42.37%
Sales past 3/5Y-3.52% 0.28%
EPS Y/Y TTM5.33%
Sales Y/Y TTM-12.50%
EPS Q/Q139.93%
Sales Q/Q-7.90%
EarningsNov 04 AMC
EPS/Sales Surpr.- -

Ownership

Insider Own4.81%
Insider Trans0.00%
Inst Own-
Inst Trans-8.12%
ROA-4.10%
ROE-30.23%
ROIC-9.96%
Gross Margin28.01%
Oper. Margin-0.63%
Profit Margin-4.41%
SMA20-36.44%
SMA50-58.50%
SMA200-75.59%
Trades-

Technical

Shs Outstand2.99M
Shs Float2.86M
Short Float4.90%
Short Ratio0.74
Short Interest0.14M
52W High47.60 -93.01%
52W Low2.88 15.45%
Volatility18.49% 12.62%
ATR (14)0.82
RSI (14)25.13
Beta1.44
Rel Volume0.47
Avg Volume188.84K
Volume62,797

Performance

Perf Week-44.25%
Perf Month-56.32%
Perf Quarter-69.83%
Perf Half Y-72.48%
Perf YTD-89.92%
Perf Year-92.90%
Perf 3Y-96.63%
Perf 5Y-98.55%
Perf 10Y-98.45%
Recom3.00
Target Price14.00
Prev Close3.19
Price3.33
Change %4.23%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
May 07, 2026DowngradeBBTIG ResearchBuy → Neutral
Feb 13, 2024InitiatedRROTH MKMBuy$9+170.7%
Jun 23, 2022InitiatedRB. Riley SecuritiesBuy$7.50+125.6%
Dec 22, 2021InitiatedLLoop CapitalBuy$7.50+125.6%
Jan 21, 2020UpgradeBBTIG ResearchNeutral → Buy$9.50+185.7%
Nov 01, 2018UpgradeCCitigroupSell → Neutral
Dec 13, 2017DowngradeJJP MorganNeutral → Underweight
Nov 30, 2017InitiatedLLake StreetBuy$10+200.8%
Dec 14, 2016DowngradeJJP MorganOverweight → Neutral
Dec 22, 2015InitiatedRRBC Capital MktsSector Perform$8+140.6%

Peers

Mkt cap
TickerCompanyMkt cap
VREXVarex Imaging Corp783.03M
SRTSSensus Healthcare Inc55.55M
ITOCiTonic Holdings Ltd13.31M
NVCRNovoCure Ltd1.39B
CCMConcord Medical Services ADR10.12M
AMSAmerican Shared Hospital Services7.85M
GEHCGE HealthCare Technologies Inc37.42B
CATXPerspective Therapeutics Inc101.43M
LNTHLantheus Holdings Inc6.64B
RDNTRadnet Inc6.17B

Insider trading

latest 14 of 22
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
La Neve Stephen R.CEOOct 31 '26Option Exercise0.00312,5000332,500Nov 02 04:10 PM
MURPHY MICHAEL JOHNVP, Corporate ControllerOct 31 '26Option Exercise0.0037,500062,999Nov 02 04:10 PM
LEONEL PERALTAOfficerJun 12 '26Proposed Sale0.3554,75419,377Jun 12 04:06 PM
Peralta LeonelSVP, Chief Operations OfficerFeb 28 '26Option Exercise0.0083,723083,723Mar 03 04:10 PM
MAYER STEVEN FDirectorFeb 20 '26Buy0.5654,87530,8781,545,620Feb 23 04:10 PM
MAYER STEVEN FDirectorFeb 18 '26Buy0.53126,12567,1991,421,745Feb 20 04:10 PM
MAYER STEVEN FDirectorFeb 19 '26Buy0.5369,00036,5981,490,745Feb 20 04:10 PM
Scott Byron CDirectorDec 31 '25Option Exercise0.009,4330162,727Jan 09 07:33 PM
Kill RobertFormer DirectorDec 22 '25Proposed Sale0.92262,809241,784Dec 22 03:49 PM
Pervaiz AliSVP Chief Financial OfficerNov 29 '25Option Exercise0.0044,0250410,204Dec 02 05:30 PM
Chalke SandeepSVP, Chief Commercial OfficerNov 29 '25Option Exercise0.0050,3140524,283Dec 02 05:30 PM
Chew JesseOfficerDec 01 '25Proposed Sale1.0219,99320,393Dec 02 11:55 AM
Winter Suzanne COfficerDec 01 '25Proposed Sale1.0268,05869,419Dec 02 11:35 AM
WHITTERS JOSEPH EDirectorNov 21 '25Option Exercise0.0056,6030667,656Nov 25 05:55 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VXFVanguard Extended Market Index ETFAUM: 30.47B
FESMFidelity Enhanced Small Cap Core ETFAUM: 6.82B
MSSMMorgan Stanley Pathway Small-Mid Cap Equity ETFAUM: 705.72M
PRFZInvesco RAFI US 1500 Small-Mid ETFAUM: 2.66B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2027Q12026-11-042.800--3.60086.52--
2026Q42026-08-19-0.800--0.614100.92105.3-
2026Q32026-05-06-3.600-2.000-3.799104.85111.91
2026Q22026-02-04-4.400-4.304-4.553102.24100.861
2026Q12025-11-05-7.200-1.888-7.29093.9491.341
2025Q42025-08-130.4000.5320.412127.54123.783
2025Q32025-04-30-0.400-2.132-0.504113.24101.533
2025Q22025-02-050.800-1.0920.978116.17110.343
2025Q12024-11-06-1.600-2.000-1.578101.5597.553
2024Q42024-08-141.2001.2000.034134.29121.53
2024Q32024-05-01-2.400-0.500-0.064101.13115.964
2024Q22024-01-31-4.000-2.040-0.098107.24106.673
2024Q12023-11-07-1.200-2.000-0.031103.8997.624
2023Q42023-08-09-1.2000.400-0.027118.29121.755
2023Q32023-04-260.400-0.4680.006118.1109.776
2023Q22023-02-01-0.800-1.060-0.020114.76107.036

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2017FY-14.400-11.376-0.360383.41383.18
2018FY-11.200-11.572-0.282404.9398.36
2019FY-7.600-6.648-0.188418.8417.66
2020FY1.2000.6000.042382.93379.52
2021FY-2.8001.120-0.069396.29387.47
2022FY-2.400-3.400-0.058429.91425.2
2023FY-4.000-2.600-0.098447.61451.06
2024FY-6.400-6.800-0.158446.55433.76
2025FY-0.800-0.532-0.619458.51454.74
2026FY-16.000--0.800401.95406.3
2027FY--9.600--412.59
2028FY--5.600--422.7

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2027Q2S2026-05-0710199.9999.9999.99
2027Q2S2026-04-21100113.29113.29113.29
2027Q2S2026-04-10101113.29113.29113.29
2027Q2S2026-02-05101113.3113.3113.3
2027Q2S2026-01-20100115.23115.23115.23
2027Q2S2025-11-11101115.23115.23115.23
2027Q2S2025-11-10101115.23115.23115.23
2027Q2S2025-11-09101115.23115.23115.23
2027Q2S2025-11-08101115.23115.23115.23
2027Q2S2025-11-07101115.23115.23115.23
2027Q2S2025-11-06101115.23115.23115.23
2027Q2S2025-11-05100126.96126.96126.96
2027Q2S2025-11-04100126.96126.96126.96
2027Q2R2025-11-111000.000.000.00

Estimate history

EPS, annual-0.282-0.1880.042-0.069-0.058-0.098-0.158-0.619-16.046-6.0556
Period201820192020202120222023202420252026TTM
EPS, quarterly-1.5780.978-0.5040.412-7.29-4.553-3.799-0.6142.911
PeriodQ1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27
Sales, annual404.897418.785382.928396.289429.909447.605446.551458.505401.947394.53
Period201820192020202120222023202420252026TTM
Sales, quarterly101.545116.174113.243127.54393.942102.241104.845100.91986.523
PeriodQ1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27
Shares, annual86.12988.52291.17890.82293.596.535100.1952.8162.9862.989
Period201820192020202120222023202420252026MRQ
Shares, quarterly2.5112.572.5712.8162.8322.972.9732.9862.989
PeriodQ1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

Income statement, annual

Currency USD, millions
MetricTTM2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Total Revenue394.53401.95458.50446.55447.61429.91396.29382.93418.79
Cost of Goods Sold Incl. D&A284.00290.49311.54303.43293.64269.95236.78233.21256.13
Gross Profit110.53111.45146.97143.12153.96159.96159.51149.72162.65
Selling, General and Administrative Excl. Other113.02121.72139.13140.02148.88151.81137.27136.08160.57
Research and Development34.3537.7547.9448.0357.1357.7552.7349.7856.49
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-2.50-10.277.843.105.088.1522.2313.642.08
Interest Expense39.1435.3112.9511.6210.638.1316.8918.0815.08
Unusual Expense-18.269.401.403.210.822.0412.300.361.48
Net Income Before Taxes-15.39-47.251.13-11.82-6.79-2.00-4.565.69-14.34
Income Taxes1.991.952.733.732.493.351.751.862.09
Consolidated Net Income-17.38-49.19-1.59-15.54-9.28-5.35-6.313.83-16.43
Net Income From Continuing Operations-17.38-49.19-1.59-15.54-9.28-5.35-6.313.83-16.43
Net Income-17.38-49.19-1.59-15.54-9.28-5.35-6.313.83-16.43
EPS (Recurring)-8.67-13.90-0.24-0.14-0.09-0.040.020.04-0.18
EPS (Basic, Before Extraordinaries)-6.03-16.05-0.62-0.16-0.10-0.06-0.070.04-0.19
EPS (Diluted)-6.06-16.05-0.62-0.16-0.10-0.06-0.070.04-0.19
EBITDA11.232.9213.999.019.6113.6628.6221.1812.57
Non-Operating Income (Expense)7.987.737.65-0.09-0.420.022.4010.490.14
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense4.005.108.067.497.948.376.815.957.74
Price To Earnings Ratio-------61.40-
Price To Sales Ratio0.100.080.310.400.820.421.050.480.81
Gross Margin28.0127.7332.0532.0534.4037.2140.2539.1038.84
Operating Margin-0.63-2.561.710.701.141.905.613.560.50
Net Margin-4.41-12.24-0.35-3.48-2.07-1.24-1.591.00-3.92
Shares Outstanding2.992.992.82100.1996.5393.5090.8291.1888.52
Market Capitalization9.579.57154.327,224.9814,943.567,330.3616,420.567,403.6613,625.51

Income statement, quarterly

Currency USD, millions
Metric2027Q12026Q42026Q32026Q22026Q12025Q42025Q32025Q2
Total Revenue86.52100.92104.84102.2493.94127.54113.24116.17
Cost of Goods Sold Incl. D&A60.4465.8479.5578.1766.9988.5681.6274.28
Gross Profit26.0835.0825.2924.0726.9538.9831.6341.89
Selling, General and Administrative Excl. Other26.8128.8127.8429.5636.7634.7430.5837.19
Research and Development7.817.718.1810.6511.2711.4710.7113.64
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-0.736.27-2.55-5.49-9.814.231.054.71
Interest Expense11.8811.108.457.718.054.232.892.88
Unusual Expense-22.640.043.580.763.71-0.430.630.63
Net Income Before Taxes10.65-1.51-11.34-13.20-21.212.07-0.843.23
Income Taxes0.520.430.470.570.470.950.460.69
Consolidated Net Income10.13-1.94-11.80-13.77-21.681.12-1.302.54
Net Income From Continuing Operations10.13-1.94-11.80-13.77-21.681.12-1.302.54
Net Income10.13-1.94-11.80-13.77-21.681.12-1.302.54
EPS (Recurring)-1.64-0.61-2.99-4.38-6.420.30-0.331.15
EPS (Basic, Before Extraordinaries)2.93-0.61-3.80-4.55-7.290.42-0.501.00
EPS (Diluted)2.91-0.61-3.80-4.55-7.290.41-0.500.98
EBITDA2.689.710.84-2.00-6.525.832.626.22
Non-Operating Income (Expense)0.623.373.230.760.371.641.632.03
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.891.331.090.701.992.232.171.80
Price To Earnings Ratio------302.36-
Price To Sales Ratio0.100.080.110.230.440.330.400.45
Gross Margin30.1534.7624.1323.5428.6930.5627.9336.06
Operating Margin-0.846.21-2.43-5.37-10.453.320.924.05
Net Margin11.71-1.92-11.26-13.47-23.080.88-1.152.18
Shares Outstanding2.992.992.972.972.832.822.572.57
Market Capitalization9.5730.7946.1697.95189.18154.32184.10203.56

Balance sheet, annual

Currency USD, millions
Metric2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Cash & Short Term Investments41.2357.9969.0689.9388.94116.93108.5787.0292.91
Short Term Receivables85.9598.1599.1686.8795.8085.8791.09111.8965.99
Inventories147.07141.02138.32145.15142.25125.93134.37120.82108.54
Other Current Assets11.5516.5913.9713.7322.4421.0420.7324.2015.57
Total Current Assets285.81313.75320.51335.68349.43349.76354.77343.93283.02
Net Property, Plant & Equipment54.8361.7758.5546.7829.4834.8544.0017.1223.70
Total Investments and Advances12.588.7611.1616.4015.0917.2115.271.160.62
Long-Term Note Receivable6.493.953.298.458.749.448.944.276.89
Intangible Assets71.8068.0757.7357.8958.0958.4058.3858.4558.68
Deferred Tax Assets0.430.760.66------
Other Assets11.7413.1816.7314.0112.0110.449.5713.255.83
Total Assets443.68470.24468.63479.21472.85480.10490.93438.18378.73
Short Term Debt Incl. Current Port. of LT Debt13.5720.1113.979.8717.1311.968.220.000.00
Accounts Payable40.5534.0350.0233.7431.3419.4723.1329.5619.69
Income Tax Payable0.330.971.21------
Other Current Liabilities136.95137.46130.07155.03160.39160.93150.92162.62149.74
Total Current Liabilities191.41192.58195.27198.64208.86192.36182.27192.18169.43
Long Term Debt174.14156.27196.77195.16182.36187.45213.48159.84131.08
Provision for Risks Charges1.022.392.730.630.100.000.000.000.00
Other Liabilities35.4137.8328.7731.1328.3431.4531.5436.2829.58
Total Liabilities401.98389.07423.54425.56419.66411.26427.29388.31330.10
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity41.7081.1745.0853.6653.1968.8463.6349.8748.63
Total Shareholders Equity41.7081.1745.0853.6653.1968.8463.6349.8748.63
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity41.7081.1745.0853.6653.1968.8463.6349.8748.63
Total Liabilities & Stockholders Equity443.68470.24468.63479.21472.85480.10490.93438.18378.73
Book Value Per Share13.9728.820.450.560.570.760.700.560.56
Tangible Book Value Per Share-10.084.65-0.13-0.04-0.050.120.06-0.10-0.12
Full-Time Employees8099909871,0241,044995932947998
Price to Book Ratio0.181.90175.87278.49137.82238.53116.35285.98313.45
Return on Assets-10.77-0.34-3.28-1.95-1.12-1.300.82-4.02-6.09
Return on Equity-80.08-2.52-31.49-17.37-8.76-9.536.74-33.36-50.23
Return on Invested Capital-22.79-0.67-6.43-3.73-2.27-2.461.38-7.83-13.30
Quick Ratio0.720.900.930.960.991.161.211.161.03
Current Ratio1.491.631.641.691.671.821.951.791.67

Cash flow, annual

Currency USD, millions
MetricTTM2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Net Income-17.38-49.19-1.59-15.54-9.28-5.35-6.313.83-16.43
Depreciation8.297.946.155.914.535.516.397.5410.49
Other Funds (Non Cash)-4.5221.7916.3518.2515.2118.2530.758.6923.10
Funds from Operations-13.06-18.8421.0610.0210.9220.2030.7120.0617.08
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-10.7511.86-18.20-21.924.62-22.607.80-21.53-46.72
Cash from Operating Activities-23.82-6.982.86-11.9015.54-2.4038.51-1.47-29.64
Capital Expenditures-13.46-12.28-8.52-3.60-12.68-4.72-2.32-3.73-4.31
Net Assets From Acquisitions0.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00-
Purchase or Sale of Investments0.000.000.000.000.000.00-0.080.000.00
Purchase of Investments0.000.000.000.000.000.00-0.080.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-13.46-12.28-8.52-3.60-12.68-4.72-2.40-3.73-4.31
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock0.670.671.632.252.203.89-11.052.453.93
Repurchase of Common Pref Stock0.000.000.000.000.000.00-14.080.000.00
Sale of Common Pref Stock0.670.671.632.252.203.893.032.453.93
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net3.006.36-5.79-6.08-4.11-19.00-17.4124.4524.55
Change in Long Term Debt3.006.36-5.79-6.08-4.11-19.00-17.4124.4524.55
Issuance of Long Term Debt40.7242.72163.714.924.750.00103.6524.7224.55
Reduction of Long Term Debt-37.72-36.35-169.50-11.00-8.87-19.00-121.07-0.260.00
Net Financing Active Other Cash Flow14.95-0.05-0.09-0.12-0.20-0.26-0.34-0.210.00
Other Financing Activities Uses-0.05-0.05-0.09-0.12-0.20-0.26-0.34-0.210.00
Cash from Financing Activities18.616.98-4.25-3.95-2.11-15.37-28.8026.7028.47
Exchange Rate Effect-0.88-1.081.66-1.350.30-5.560.980.230.12
Net Change in Cash-19.54-13.37-8.26-20.811.05-28.058.2921.73-5.36
Free Cash Flow-27.90-12.84-1.41-15.512.92-7.1236.19-5.03-33.95
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow----125.54-11.49--
Deferred Taxes & Investment Tax Credit-0.620.161.400.461.78-0.110.00-0.09

Balance sheet, quarterly

Currency USD, millions
Metric2027Q12026Q42026Q32026Q22026Q12025Q4
Cash & Short Term Investments43.0841.2338.5341.8763.9257.99
Short Term Receivables60.4285.9580.7473.2861.4398.15
Inventories146.08147.07156.63150.96155.50141.02
Other Current Assets14.3911.5515.5222.8120.4116.59
Total Current Assets263.98285.81291.42288.92301.26313.75
Net Property, Plant & Equipment52.0554.8357.9060.0661.1161.77
Total Investments and Advances12.6312.5812.3211.9610.048.76
Intangible Assets40.8871.8071.4170.9370.1368.07
Deferred Tax Assets0.440.430.690.710.740.76
Other Assets12.3711.7410.4512.3611.4313.18
Total Assets390.06443.68447.60448.01456.82470.24
Short Term Debt Incl. Current Port. of LT Debt14.5513.5719.3919.2720.3220.11
Accounts Payable33.0540.5552.8043.5242.4034.03
Income Tax Payable0.390.331.331.230.800.97
Other Current Liabilities122.12136.95132.32135.42131.09137.46
Total Current Liabilities170.11191.41205.84199.44194.61192.58
Long Term Debt121.42174.14163.01154.96158.80156.27
Provision for Risks Charges0.001.020.000.000.002.39
Other Liabilities45.4135.4137.0440.1941.5437.83
Total Liabilities336.94401.98405.89394.59394.95389.07
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity53.1241.7041.7153.4261.8781.17
Total Shareholders Equity53.1241.7041.7153.4261.8781.17
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity53.1241.7041.7153.4261.8781.17
Total Liabilities & Stockholders Equity390.06443.68447.60448.01456.82470.24
Book Value Per Share17.7713.9714.0317.9921.8528.82
Tangible Book Value Per Share4.09-10.08-9.99-5.90-2.924.65
Full-Time Employees-809---990
Price to Book Ratio0.180.741.111.833.061.90
Return on Assets-4.10-10.77-9.90-7.69-4.15-0.34
Return on Equity-30.23-80.08-101.06-70.32-36.07-2.52
Return on Invested Capital5.81-0.90-5.77-6.61-9.820.47
Quick Ratio0.690.720.650.690.750.90
Current Ratio1.551.491.421.451.551.63

Cash flow, quarterly

Currency USD, millions
Metric2027Q12026Q42026Q32026Q22026Q12025Q4
Net Income10.13-1.94-11.80-13.77-21.681.12
Depreciation2.032.022.082.161.681.60
Other Funds (Non Cash)-15.207.154.14-0.6111.115.49
Funds from Operations-3.127.80-5.55-12.18-8.908.26
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-1.53-5.37-0.05-3.8021.08-17.96
Cash from Operating Activities-4.662.43-5.60-15.9912.18-9.71
Capital Expenditures-5.00-1.35-1.51-5.60-3.82-3.40
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-5.00-1.35-1.51-5.60-3.82-3.40
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.000.150.000.520.000.77
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.000.150.000.520.000.77
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-3.843.484.11-0.75-0.47-6.62
Change in Long Term Debt-3.843.484.11-0.75-0.47-6.62
Issuance of Long Term Debt0.0031.604.494.622.00136.88
Reduction of Long Term Debt-3.84-28.13-0.38-5.38-2.48-143.50
Net Financing Active Other Cash Flow15.000.00-0.00-0.050.000.00
Other Financing Activities Uses0.000.00-0.00-0.050.000.00
Cash from Financing Activities11.163.624.11-0.28-0.47-5.84
Exchange Rate Effect0.12-0.37-0.43-0.20-0.090.84
Net Change in Cash1.624.32-3.43-22.067.79-18.11
Free Cash Flow-4.781.97-6.07-19.0110.28-11.03
Price to Free Cash Flow----11.50-

Revenue breakdown

Product2025: 237.58M
Service2025: 220.93M
Total Surgical & Medical Instruments & Apparatus revenue2026: 401.95M
Americas2025: 88.77M
Asia Pacific2025: 47.38M
China2025: 124.48M
EIMEA2025: 144.26M
Japan2025: 53.62M
United States2026: 401.95M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-304.91%0.1M2.9M179.96K
2026-10-154.42%0.1M2.9M179.03K
2026-09-306.47%0.2M2.9M177.30K
2026-09-154.33%0.1M2.9M31.61K
2026-08-314.37%0.1M2.9M37.34K
2026-08-144.09%0.1M2.9M82.53K
2026-07-315.03%0.1M2.9M88.05K
2026-07-154.15%0.1M2.8M85.04K
2026-06-304.25%0.1M2.8M85.01K
2026-06-156.10%0.2M2.8M80.56K
2026-05-297.15%0.2M2.8M79.93K
2026-05-155.83%0.2M2.8M51.77K
2026-04-306.09%0.2M2.8M33.29K
2026-04-156.99%0.2M2.8M32.08K
2026-03-316.74%0.2M2.8M28.44K
2026-03-135.85%0.2M2.8M27.00K
2026-02-274.85%0.1M2.8M25.92K
2026-02-135.04%0.1M2.8M26.56K
2026-01-304.48%0.1M2.7M25.76K
2026-01-153.83%0.1M2.7M26.80K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call0.500.000.000.05-3310.00---
call1.000.000.000.00-0.000.00---
call1.500.000.000.00-0.000.00---
call2.000.000.000.00-0.000.00---
call3.000.000.000.00-0.000.00---
put0.500.000.000.33-21.000.00---
put1.000.000.000.82-27.000.00---
put1.500.000.001.33-37.000.00---
put2.000.000.001.82-15.000.00---
put3.000.000.002.83-2.000.00---

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-048-KCurrent report2026-11-04SEC
2026-11-048-KCurrent report2026-11-04SEC
2026-11-024Statement of changes in beneficial ownership of securities2026-10-31SEC
2026-11-024Statement of changes in beneficial ownership of securities2026-10-31SEC
2026-10-30S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-10-16ARSAnnual report to security holders. 2026-06-30SEC
2026-10-16DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-11-19SEC
2026-10-138-KCurrent report2026-10-08SEC
2026-10-074Statement of changes in beneficial ownership of securities2026-10-05SEC
2026-10-073Initial statement of beneficial ownership of securities2026-10-05SEC
2026-10-068-KCurrent report2026-10-05SEC
2026-10-014Statement of changes in beneficial ownership of securities2026-09-23SEC
2026-09-18DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-09-11EFFECTEffectiveness filing by commission orderSEC
2026-09-11424B3SEC
2026-09-09S-3/ASEC
2026-09-02SCHEDULE 13D/ASEC
2026-09-024Statement of changes in beneficial ownership of securities2026-07-29SEC
2026-08-2710-KAnnual report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-24DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-10-06SEC
2026-08-21S-3/ASEC
2026-08-198-KCurrent report2026-08-19SEC
2026-08-12PRE 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-10-06SEC
2026-08-068-KCurrent report2026-08-04SEC
2026-08-05SCHEDULE 13G/ASEC
2026-07-31S-3Registration statement for specified transactions by certain issuers including face-amount certificate companiesSEC
2026-07-298-KCurrent report2026-07-29SEC
2026-07-27SCHEDULE 13G/ASEC
2026-07-07SCHEDULE 13GSEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-02134.68K300
2026-010000
2025-120000
2025-1119.41K100

Institutional holders

Manager% owned
TCW GROUP INC23.05%
Neuberger Berman Group LLC5.11%
ARMISTICE CAPITAL, LLC4.82%
WEBER CAPITAL MANAGEMENT LLC /ADV4.05%
VANGUARD CAPITAL MANAGEMENT LLC3.73%
BlackRock, Inc.2.75%
AQR CAPITAL MANAGEMENT LLC2.29%
JANE STREET GROUP, LLC1.80%
RENAISSANCE TECHNOLOGIES LLC1.74%
DAFNA Capital Management LLC1.41%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND2.62%
Neuberger Intrinsic Value Fund1.18%
VANGUARD EXTENDED MARKET INDEX FUND1.00%
Fidelity Enhanced Small Cap Core ETF1.00%
Fidelity Small Cap Index Fund0.82%
Fidelity Extended Market Index Fund0.58%
VANGUARD RUSSELL 2000 INDEX FUND0.43%
Column Small Cap Select Fund0.32%
iShares Russell 2000 ETF0.30%
Goldman Sachs Absolute Return Tracker Fund0.21%

OakChart. ARAY. Cached 15 minutes.